Matrix metalloproteinases and tissue inhibitors of metalloproteinases in extracellular matrix remodeling during left ventricular diastolic dysfunction and heart failure …
MM Krebber, CGM Van Dijk, RWM Vernooij… - International journal of …, 2020 - mdpi.com
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are
pivotal regulators of extracellular matrix (ECM) composition and could, due to their dynamic …
pivotal regulators of extracellular matrix (ECM) composition and could, due to their dynamic …
Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation
N Nishikawa, K Yamamoto, Y Sakata… - Cardiovascular …, 2003 - academic.oup.com
Objective: Remodeling of extracellular matrix (ECM) is considered to contribute to
progression of left ventricular (LV) remodeling and matrix metalloproteinases (MMPs) play …
progression of left ventricular (LV) remodeling and matrix metalloproteinases (MMPs) play …
Matrix metalloproteinase therapy in heart failure
FG Spinale, NM Wilbur - Current treatment options in cardiovascular …, 2009 - Springer
Opinion statement Milestones in the progression to heart failure following myocardial
infarction (MI) are changes in left ventricular (LV) geometry and function, termed post-MI …
infarction (MI) are changes in left ventricular (LV) geometry and function, termed post-MI …
Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in …
J George, S Patal, D Wexler, A Roth, D Sheps… - American heart …, 2005 - Elsevier
BACKGROUND: Extracellular matrix remodeling is thought to play an important role in the
progression of heart failure (HF). Matrix metalloproteinases (MMPs) and tissue inhibitors of …
progression of heart failure (HF). Matrix metalloproteinases (MMPs) and tissue inhibitors of …
Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure
BACKGROUND: Matrix metalloproteinases (MMPs) can alter myocardial extracellular matrix
and thereby contribute to adverse ventricular remodeling in progressive heart failure (HF) …
and thereby contribute to adverse ventricular remodeling in progressive heart failure (HF) …
Dynamic role of extracellular matrix metalloproteinases in heart failure
SC Tyagi - Cardiovascular Pathology, 1998 - Elsevier
In chronic congestive heart failure, an illness affecting more than 4 million Americans, there
is extensive myocardial extracellular matrix (ECM) remodeling. Failing human ventricular …
is extensive myocardial extracellular matrix (ECM) remodeling. Failing human ventricular …
Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors
Z Kassiri, R Khokha - Thrombosis and haemostasis, 2005 - thieme-connect.com
Cardiovascular disease poses a major health care burden in the Western world. Following
myocardial injuries, ventricular remodelling and dysfunction ensue, which can eventually …
myocardial injuries, ventricular remodelling and dysfunction ensue, which can eventually …
Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy
TY Hsia, JM Ringewald, RE Stroud… - European journal of …, 2011 - Wiley Online Library
Aims The left ventricular phenotype of idiopathic dilated cardiomyopathy (DCM) can appear
similar in paediatric and adult patients. However, the aetiology of paediatric DCM is usually …
similar in paediatric and adult patients. However, the aetiology of paediatric DCM is usually …
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
YY Li, CF McTiernan, AM Feldman - Cardiovascular research, 2000 - academic.oup.com
Myocardial fibrosis due to maladaptive extracellular matrix remodeling contributes to
dysfunction of the failing heart. Further elucidation of the mechanism by which myocardial …
dysfunction of the failing heart. Further elucidation of the mechanism by which myocardial …
Matrix metalloproteinases: pathways of induction by bioactive molecules
T Tsuruda, LC Costello-Boerrigter, JC Burnett - Heart failure reviews, 2004 - Springer
Regulation of the extracellular matrix (ECM) is an important therapeutic target that can
potentially attenuate the adverse ventricular remodeling seen in the progression of heart …
potentially attenuate the adverse ventricular remodeling seen in the progression of heart …
相关搜索
- heart failure matrix metalloproteinases
- tissue inhibitors matrix metalloproteinases
- heart failure ejection fraction
- heart failure tissue inhibitors
- tissue inhibitors ejection fraction
- ejection fraction matrix remodeling
- tissue inhibitors meta analysis
- heart failure meta analysis
- meta analysis matrix remodeling
- ventricular dilatation matrix metalloproteinases
- heart failure ventricular dilatation
- ejection fraction meta analysis
- ventricular volumes plasma matrix
- ejection fraction ventricular volumes
- tissue inhibitor outcome in patients
- pathways of induction matrix metalloproteinases